鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/16 | 2,757 | 2,773 | 2,718 | 2,724 | -42 | -1.5% | 76,100 |
2021/08/13 | 2,715 | 2,778 | 2,707 | 2,766 | +65 | +2.4% | 67,100 |
2021/08/12 | 2,674 | 2,723 | 2,658 | 2,701 | +23 | +0.9% | 44,500 |
2021/08/11 | 2,660 | 2,682 | 2,635 | 2,678 | +24 | +0.9% | 29,800 |
2021/08/10 | 2,600 | 2,664 | 2,600 | 2,654 | +53 | +2% | 43,700 |
2021/08/06 | 2,621 | 2,633 | 2,600 | 2,601 | -37 | -1.4% | 41,100 |
2021/08/05 | 2,620 | 2,658 | 2,620 | 2,638 | +23 | +0.9% | 39,600 |
2021/08/04 | 2,637 | 2,647 | 2,607 | 2,615 | -20 | -0.8% | 51,700 |
2021/08/03 | 2,650 | 2,670 | 2,617 | 2,635 | -18 | -0.7% | 60,400 |
2021/08/02 | 2,538 | 2,710 | 2,530 | 2,653 | +115 | +4.5% | 169,900 |
2021/07/30 | 2,622 | 2,625 | 2,500 | 2,538 | -78 | -3% | 103,000 |
2021/07/29 | 2,629 | 2,634 | 2,567 | 2,616 | -9 | -0.3% | 240,600 |
2021/07/28 | 2,569 | 2,627 | 2,568 | 2,625 | +36 | +1.4% | 81,900 |
2021/07/27 | 2,575 | 2,605 | 2,550 | 2,589 | +32 | +1.3% | 74,100 |
2021/07/26 | 2,560 | 2,578 | 2,545 | 2,557 | +38 | +1.5% | 56,900 |
2021/07/21 | 2,500 | 2,551 | 2,486 | 2,519 | +27 | +1.1% | 67,900 |
2021/07/20 | 2,476 | 2,496 | 2,461 | 2,492 | -15 | -0.6% | 56,500 |
2021/07/19 | 2,502 | 2,520 | 2,487 | 2,507 | -11 | -0.4% | 44,100 |
2021/07/16 | 2,518 | 2,541 | 2,512 | 2,518 | -9 | -0.4% | 41,000 |
2021/07/15 | 2,496 | 2,540 | 2,495 | 2,527 | +55 | +2.2% | 62,000 |
2021/07/14 | 2,495 | 2,495 | 2,458 | 2,472 | -16 | -0.6% | 27,400 |
2021/07/13 | 2,450 | 2,491 | 2,424 | 2,488 | +44 | +1.8% | 59,400 |
2021/07/12 | 2,398 | 2,450 | 2,398 | 2,444 | +64 | +2.7% | 76,100 |
2021/07/09 | 2,368 | 2,384 | 2,322 | 2,380 | -17 | -0.7% | 81,500 |
2021/07/08 | 2,440 | 2,449 | 2,397 | 2,397 | -7 | -0.3% | 84,100 |
2021/07/07 | 2,421 | 2,444 | 2,403 | 2,404 | -27 | -1.1% | 45,400 |
2021/07/06 | 2,443 | 2,450 | 2,425 | 2,431 | -6 | -0.2% | 30,100 |
2021/07/05 | 2,459 | 2,476 | 2,437 | 2,437 | -12 | -0.5% | 32,000 |
2021/07/02 | 2,470 | 2,473 | 2,447 | 2,449 | +8 | +0.3% | 22,000 |
2021/07/01 | 2,435 | 2,447 | 2,411 | 2,441 | +10 | +0.4% | 31,800 |
2021/06/30 | 2,453 | 2,475 | 2,414 | 2,431 | -20 | -0.8% | 61,200 |
2021/06/29 | 2,467 | 2,467 | 2,418 | 2,451 | -23 | -0.9% | 41,100 |
2021/06/28 | 2,467 | 2,510 | 2,429 | 2,474 | +16 | +0.7% | 49,500 |
2021/06/25 | 2,435 | 2,468 | 2,425 | 2,458 | +48 | +2% | 38,000 |
2021/06/24 | 2,433 | 2,433 | 2,395 | 2,410 | -4 | -0.2% | 33,800 |
2021/06/23 | 2,434 | 2,434 | 2,398 | 2,414 | -20 | -0.8% | 57,900 |
2021/06/22 | 2,426 | 2,441 | 2,381 | 2,434 | +58 | +2.4% | 89,200 |
2021/06/21 | 2,428 | 2,448 | 2,349 | 2,376 | -74 | -3% | 95,600 |
2021/06/18 | 2,499 | 2,504 | 2,444 | 2,450 | -35 | -1.4% | 52,200 |
2021/06/17 | 2,510 | 2,525 | 2,474 | 2,485 | -26 | -1% | 41,600 |
2021/06/16 | 2,539 | 2,539 | 2,500 | 2,511 | -31 | -1.2% | 30,100 |
2021/06/15 | 2,550 | 2,563 | 2,528 | 2,542 | -5 | -0.2% | 32,800 |
2021/06/14 | 2,570 | 2,591 | 2,534 | 2,547 | -3 | -0.1% | 39,600 |
2021/06/11 | 2,549 | 2,565 | 2,516 | 2,550 | +25 | +1% | 32,800 |
2021/06/10 | 2,498 | 2,532 | 2,494 | 2,525 | +32 | +1.3% | 29,300 |
2021/06/09 | 2,481 | 2,515 | 2,472 | 2,493 | +17 | +0.7% | 25,600 |
2021/06/08 | 2,474 | 2,487 | 2,466 | 2,476 | +16 | +0.7% | 16,500 |
2021/06/07 | 2,550 | 2,550 | 2,457 | 2,460 | -64 | -2.5% | 50,800 |
2021/06/04 | 2,454 | 2,649 | 2,440 | 2,524 | +70 | +2.9% | 80,400 |
2021/06/03 | 2,440 | 2,483 | 2,438 | 2,454 | +18 | +0.7% | 29,100 |
901~
950
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 450,000円 | +7.1% | -35.0% | 2.67% | 37.21倍 | 1.04倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
サンバイオ | 239,900円 | - | - | 0.00% | - | 111.12倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
東和薬品 | 254,800円 | +15.0% | -7.3% | 2.75% | 8.36倍 | 0.79倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 230,400円 | +14.2% | +41.0% | 2.00% | 11.28倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム